Navigation Links
Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Date:11/9/2010

t adjusted for multiple comparisons and are based on an exploratory post-hoc analysis)

** BILAG (British Isles Lupus Assessment Group) is a comprehensive scoring system for assessing both current SLE disease activity and changes in that activity since the patient was last seen.For further informationScott Fleming, Global Communications Manager – ImmunologyTel: +44.770.277.7378, scott.fleming@ucb.com Nancy Nackaerts, External Communications, UCBTel: +32 473 86 44 14, nancy.nackaerts@ucb.comMichael Tuck-Sherman, Investor Relations, UCBTel: +32.2.559.9712, michael.tuck-sherman@ucb.com  Richard Simpson, Investor Relations, UCBTel: +32.2.559.9494, richard.simpson@ucb.comAntje Witte, Investor Relations, UCBTel: +32 2559 9414 / +492173481866, antje.witte@ucb.comAbout EpratuzumabEpratuzumab is a humanized anti-CD22 monoclonal antibody under investigation for the treatment of SLE. CD22 is a B cell specific surface protein that is considered to be involved in B cell function.  The product was licensed from Immunomedics, Inc., Morris Plains, NJ, USA. Under the license agreement, UCB owns the rights and is responsible for the clinical development, and commercialization of epratuzumab in all autoimmune disorders including SLE.

About EMBLEM™In EMBLEM™ (n = 227) patients were randomized to 1 of 6 intravenous regimens: placebo (PBO), epratuzumab cumulative dose (cd) 200, 800, 2400, or 3600 mg in equal divided doses using 2 every other week (EOW) infusions or epratuzumab cd 2400 mg delivered as 4 equal infusions 1 week apart. Concomitant oral corticosteroids (CS) and immunosuppressives (IS) were stable
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... DIEGO , Oct. 21, 2014   ... today the latest genomics research centers to purchase ... Salk Institute, the National Cancer Institute (NCI), NIH ... Sequencing Center). Before Irys, obtaining a comprehensive view ... next generation sequencing (NGS) does not deliver the ...
(Date:10/22/2014)... Oct. 21, 2014 Influenza will affect as many ... the United States as high as ... to spread is from person to person in respiratory droplets ... serve way of death, but kills much fewer people each ... done by human fluids including sweat, saliva, blood and other ...
(Date:10/22/2014)... -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) – According ... Data Services, demand for thermometers is expected to grow ... demand for more accurate digital thermometers continues.  ... market for thermometers, and one of the companies serving ... Inc. Sanomedics International Holdings designs, develops, markets, ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2
(Date:10/22/2014)... Isabel Healthcare will participate in ... Conference on October 22-24 in Las Vegas, NV. Jason ... panel discussion on Technology in Health Professions Education – ... diagnostic decision support tool and clinical education platform designed ... and clinical learners. The Isabel tools help clinicians broaden ...
(Date:10/22/2014)... RESTON, Va. (PRWEB) October 22, 2014 ... Healthcare Innovation , which is dedicated to distribute ... efficiency of healthcare delivery worldwide announced the development ... in which patients expect when receiving healthcare. These ... definition for patient-centered care: “providing care that is ...
(Date:10/22/2014)... Plano, Texas (PRWEB) October 22, 2014 ... convenience of completing their continuing education at home ... now have access to 20 brand new, premium ... HomeCEUConnection.com’s robust catalog of over 2,000 hours ... to fully customize their educational experience. With such ...
(Date:10/22/2014)... 22, 2014 Akeso Biomedical, Inc. ... the treatment of bacterial infections, microbial biofilms, and chronic ... its board of directors. , Dr. Sinskey ... at The Massachusetts Institute of Technology, or MIT. He ... 1968. Dr. Sinskey also holds positions as Co-Director of ...
(Date:10/22/2014)... Salamon HealthDay Reporter TUESDAY, ... conventional in vitro fertilization (IVF) -- the incubation of embryos ... a device inside the vagina, new research suggests. Scientists ... called an INVOcell, might sharply cut costs for pricey IVF ... more accessible to those who don,t live near big-city assisted ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... ... announces sports drink from Swanson® FIT line: CONTEND. CONTEND contains electrolytes, amino acids, Sustamine, ... ... debuted a new sports drink called CONTEND at the Swanson Health ...
... George ... that advertising for new patients is ineffective. , ... New York, NY (Vocus) June 3, 2010 -- George Brakatselos, senior consultant ... advertising for new patients does not work. “While advertising can be an effective marketing tool ...
... ... with ProtectionPlus will further lower testing costs for healthcare practices, which ... primary focus for many Cardiology practices and hospital systems. Importantly, the ... to the provider as UND seeks to eliminate all excessive costs ...
... and the National Palliative Care Research Center (NPCRC) are awarding ... for studies aimed at reducing suffering for seriously ill patients ... the next two years. Since 2007, a collaborative effort by ... These grants, which are in addition to other grants in ...
... Dr. ... perfect nutritional storm is sweeping across America causing health-care costs to spiral to crisis levels, ... Americans shift to an anti-inflammatory diet." , ... San Bernardino, CA (Vocus) June 2, 2010 -- A perfect nutritional storm is ...
... And more than 40 percent of 20-year-olds rode in a ... 2 (HealthDay News) -- Drinking and driving among college students ... with one in five admitting to driving while drunk and ... , Equally worrisome, their tendency to drive under the influence ...
Cached Medicine News:Health News:CONTEND – A New Sports Drink from Swanson FIT 2Health News:Medical Practice Marketing Strategies and Advertising Don't Mix 2Health News:Medical Practice Marketing Strategies and Advertising Don't Mix 3Health News:UND Acquires ProtectionPlus in Ongoing Effort to Reduce Nuclear Stress Testing Costs for Physicians 2Health News:UND Acquires ProtectionPlus in Ongoing Effort to Reduce Nuclear Stress Testing Costs for Physicians 3Health News:UND Acquires ProtectionPlus in Ongoing Effort to Reduce Nuclear Stress Testing Costs for Physicians 4Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 2Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 3Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 4Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 5Health News:KCAA Radio Features Dr. Barry Sears, Creator of Zone Diet, on U.S. Obesity Crisis 2Health News:1 in 5 College Students Admitted to Drunk Driving, Study Found 2
Autolensmeter with black/white monitor and no internal printer....
FF 450plus IR Fundus camera with Visupac / System 451. High-end system for visualizing even the finest detail and reliable diagnosis....
... CL-100 measures all types ... with improved precision. The ... senses multi-focal lenses with ... makes operation easier while ...
... is designed for fast and easy operation ... mode, the readings are automatically held when ... are automatically detected. The sophisticated alignment system ... The TL-2000A has been designed with a ...
Medicine Products: